Edwards Lifesciences | EW - 销售收入

股票价格

81.22

每天变化

-1.06 -1.29%

每月一次

2.16%

每年

7.59%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 48.07B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	销售	更改		日
Abbott	USD 11.16B		300M	2026-03
Artivion	USD 115.99M		2.6M	2025-12
AtriCure	USD 140.5M		6.2M	2025-12
Baxter International	USD 2.97B		130M	2025-12
Becton, Dickinson and Co.	USD 5.3B		600M	2025-12
Boston Scientific	USD 5.2B		90M	2026-03
Cooper Companies	USD 1.02B		41.1M	2025-12
Dexcom	USD 1.26B		50M	2025-12
Edwards Lifesciences	USD 1.65B		80M	2026-03
Globus Medical	USD 826.4M		57.4M	2025-12
ICU Medical	USD 540.7M		3.7M	2025-12
Inogen	USD 74.93M		504K	2024-09
Insulet	USD 783.8M		77.5M	2025-12
Integra LifeSciences	USD 434.9M		32.84M	2025-12
Intuitive Surgical	USD 2.77B		100M	2026-03
J&J	USD 24.1B		500M	2026-03
Masimo	USD 412.5M		41M	2025-12
Medtronic	USD 9B		39M	2026-01
Merit Medical Systems	USD 393.9M		9.7M	2025-12
Stryker	USD 7.2B		1.14B	2025-12
Tandem Diabetes Care	USD 290.4M		41.15M	2025-12
Teleflex	USD 568.98M		344.02M	2025-12
Zimmer Biomet Holdings	USD 2.09B		150M	2026-03